Literature DB >> 6644096

Endocrinologic profile of patients with idiopathic melasma.

M Pérez, J L Sánchez, F Aguiló.   

Abstract

Complete endocrinologic evaluation of 9 women (ages 24-41) with idiopathic melasma (melasma not associated with pregnancy nor ingestion of oral contraceptives) was performed and compared to age- and sex-matched normal controls. Serum cortisol, adrenocorticotropin, plasma immunoreactive alpha and beta melanocyte-stimulating hormones, luteinizing hormone, follicular-stimulating hormone, estradiol and progesterone levels were performed in the basal state. Additionally, total T4, T3RU, FTI, prolactin, 2-h postprandial blood sugar, and 24-h urine for 17-hydroxysteroids and 17-ketosteroids were done and found to be normal. The melasma patients presented statistically significant increased levels of LH (p less than 0.001) and lower levels of serum estradiol (p less than 0.025) than normal controls. It is proposed that these hormonal alterations may represent subclinical evidence of a mild ovarian dysfunction which may underlie the pathogenesis of some cases of idiopathic melasma.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6644096     DOI: 10.1111/1523-1747.ep12522896

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  9 in total

1.  What should be considered in treatment of melasma.

Authors:  Hee Young Kang; Jean-Paul Ortonne
Journal:  Ann Dermatol       Date:  2010-11-05       Impact factor: 1.444

Review 2.  Can you identify this condition? Melasma.

Authors:  Patricia T Ting; Benjamin Barankin
Journal:  Can Fam Physician       Date:  2005-03       Impact factor: 3.275

3.  IgM Chlamydia Trachomatis Antibodies in Cases of Melasma.

Authors:  Mps Sawhney; R B Batra
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 4.  Melasma in Men: A Review of Clinical, Etiological, and Management Issues.

Authors:  Rashmi Sarkar; Pallavi Ailawadi; Shilpa Garg
Journal:  J Clin Aesthet Dermatol       Date:  2018-02-01

5.  Etiopathogenetic factors, thyroid functions and thyroid autoimmunity in melasma patients.

Authors:  Seray Külcü Çakmak; Nimet Özcan; Arzu Kılıç; Suha Koparal; Ferda Artüz; Atıl Çakmak; Kenan Köse
Journal:  Postepy Dermatol Alergol       Date:  2015-10-29       Impact factor: 1.837

Review 6.  Melasma: a clinical and epidemiological review.

Authors:  Ana Carolina Handel; Luciane Donida Bartoli Miot; Hélio Amante Miot
Journal:  An Bras Dermatol       Date:  2014 Sep-Oct       Impact factor: 1.896

Review 7.  Update on Melasma-Part I: Pathogenesis.

Authors:  Ana Cláudia C Espósito; Daniel P Cassiano; Carolina N da Silva; Paula B Lima; Joana A F Dias; Karime Hassun; Ediléia Bagatin; Luciane D B Miot; Hélio Amante Miot
Journal:  Dermatol Ther (Heidelb)       Date:  2022-07-29

8.  A Comparison of Low-Fluence 1064-nm Q-Switched Nd: YAG Laser with Topical 20% Azelaic Acid Cream and their Combination in Melasma in Indian Patients.

Authors:  Charu Bansal; Hira Naik; Hemanta K Kar; Amrita Chauhan
Journal:  J Cutan Aesthet Surg       Date:  2012-10

Review 9.  Acquired hyperpigmentations.

Authors:  Tania Ferreira Cestari; Lia Pinheiro Dantas; Juliana Catucci Boza
Journal:  An Bras Dermatol       Date:  2014 Jan-Feb       Impact factor: 1.896

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.